A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease

NCT00403286 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

457

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Fluticasone Propionate/Formoterol Fumarate
DRUG: Fluticasone Propionate/Formoterol Fumarate
DRUG: Fluticasone Propionate/Formoterol Fumarate
DRUG: Fluticasone Propionate/Formoterol Fumarate
DRUG: Fluticasone Propionate
DRUG: Formoterol Fumarate
DRUG: Fluticasone Propionate/Salmeterol Xinafoate
DRUG: Placebo

Sponsor

Dey